Jazz Pharmaceuticals plc
NASDAQ: JAZZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Renee D. Gala
- Employees
- 2,800
- Headquarters
- Dublin, United States
- IPO year
- 2007
- Market cap
- $14.1B
- Website
- https://www.jazzpharma.com
Loading JAZZ…
Loading profile data…Frequently asked questions about JAZZ
What does Jazz Pharmaceuticals plc (JAZZ) do?
Jazz Pharmaceuticals plc is a global biopharmaceutical firm dedicated to discovering, advancing, and bringing to market innovative medicines for conditions where treatment options are lacking, serving patients across the United States, Europe, and other international regions. Its extensive portfolio of both commercialized therapies and developme...
Where does JAZZ trade?
Jazz Pharmaceuticals plc (JAZZ) trades on the NASDAQ Global Select.
What sector is JAZZ in?
Jazz Pharmaceuticals plc (JAZZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jazz Pharmaceuticals plc?
Renee D. Gala is the chief executive officer of Jazz Pharmaceuticals plc (JAZZ).
Where is Jazz Pharmaceuticals plc headquartered?
Jazz Pharmaceuticals plc is headquartered in United States.
Does JAZZ pay a dividend?
Jazz Pharmaceuticals plc (JAZZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did JAZZ go public?
Jazz Pharmaceuticals plc (JAZZ) completed its initial public offering in 2007.